By Memorial Sloan Kettering | Wednesday, April 10, 2013
Dr. Douer, leader of the research program in acute lymphoblastic leukemia, talks about how patients are treated by a caring team that includes physicians, nurses, social workers, and support staff.
By Julie Grisham, MS, Science Writer/Editor | Monday, April 8, 2013
Memorial Sloan Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.
In the Clinic
By Media Staff | Thursday, April 4, 2013
Early research led by investigators at Memorial Sloan Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.
By Media Staff | Tuesday, April 2, 2013
In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan Kettering’s clinical research program.
By Memorial Sloan Kettering | Wednesday, March 27, 2013
Dr. Sonoda, who performs minimally invasive procedures when possible, discusses how patients at Memorial Sloan Kettering have the benefit of an entire team of physicians having input into their care.
By Memorial Sloan Kettering | Friday, March 22, 2013
To treat his soft tissue sarcoma, 50-year-old Ron Kraemer chose Memorial Sloan Kettering for care and support that could keep him playing music and working as a personal fitness trainer.
By Memorial Sloan Kettering | Monday, March 18, 2013
Medical oncologist Dr. Chung specializes in working with patients who have leukemia and bone marrow failure syndromes, from diagnosis through treatment and general medical care.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Wednesday, March 13, 2013
Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.
By Allyson Collins, MS, Science Writer/Editor | Tuesday, March 12, 2013
Gynecology Service Chief Richard Barakat comments on a recent study indicating that women treated by more-experienced physicians receive the most-appropriate care for this aggressive form of cancer.
By Memorial Sloan Kettering | Wednesday, March 6, 2013
Dr. Parra, who practices at Memorial Sloan Kettering Basking Ridge, treats prostate, kidney, and bladder cancers with the goal of extending the lives of patients, and giving them the best possible quality of life.
In the Clinic
By Julie Grisham, MS, Science Writer/Editor | Monday, March 4, 2013
Peripheral neuropathy — a nerve disorder that can cause weakness, numbness, tingling, and pain — is a common chemotherapy side effect. Treatments are available to help improve your quality of life.
By Julie Grisham, MS, Science Writer/Editor | Friday, March 1, 2013
At the seventh annual seminar for high school students and teachers, investigators discuss how cutting-edge biomedical research may ultimately contribute to better treatments for cancer patients.
By Memorial Sloan Kettering | Wednesday, February 27, 2013
Chief of the Leukemia Service Dr. Tallman discusses how experts collaborate to deliver the most-promising therapies, and how he cares for patients as if they were members of his own family.
By Celia Gittelson, BA | Monday, February 25, 2013
Our doctors introduce and apply advanced technologies in minimal-access surgery to benefit patients.
By Media Staff | Wednesday, February 20, 2013
Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.